FOXM1 is involved in TGF-β1–induced EMT, and TGF-β–based treatment has led to a dramatic increase in FOXM1 expression in non-small cell lung cancer cells [134]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.